USFDA approves 1st treatment for Ebola
Context: The The Food and Drug Administration approved the first drug for the treatment of Ebola.
- It is developed by Regeneron Pharmaceuticals for treating adults and children.
- It was tested during an outbreak in Congo that killed nearly 2,300 people before it ended in June.
Inmazeb (IN’-meh-zehb)
- The drug, named Inmazeb (IN’-meh-zehb), dramatically increased survival in study participants, compared to three other treatments.
- Regeneron’s treatment is a combination of three antibodies that work by killing the virus.
Ebola virus disease
- It is a viral hemorrhagic fever of humans and other primates caused by ebolaviruses.
- It is a rare but severe, often fatal illness in humans.
- The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.
- The FDA approved the first vaccine for Ebola in last December.
- An Ebola vaccine, rVSV-ZEBOV, was approved in the United States in December 2019. It appears to be fully effective ten days after being given.
1.png)
